Clincosm LogoSign in Get a demo

acute myeloid leukemia, in relapse

Showing 1 - 25 of 29
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • (no location specified)
Nov 9, 2023

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Acute Myeloid Leukemia, in Relapse
  • anti Tim-3/CD123 CAR-T cell therapy
  • Xuzhou, Jiangsu, China
    Kailin Xu
Nov 4, 2023

Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Acute Myeloid Leukemia Trial in United States

Recruiting
  • Refractory Acute Myeloid Leukemia
  • +4 more
  • CD371-YSNVZ-IL18 CAR T cells
  • Basking Ridge, New Jersey
  • +6 more
Aug 29, 2023

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Germany (Cyclophosphamide (Non-IMP,

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • Cyclophosphamide (Non-IMP, Lymphodepletion)
  • +3 more
  • Ulm, Baden-Württemberg, Germany
  • +4 more
Jul 24, 2023

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, Granulocytic Sarcoma Trial in Winston-Salem (drug,

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • +2 more
  • CPI 613
  • +3 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
May 10, 2023

Acute Myeloid Leukemia, Mixed Lineage Acute Leukemia, Mixed Lineage Leukemia Gene Mutation Trial (Ziftomenib, Venetoclax,

Not yet recruiting
  • Acute Myeloid Leukemia
  • +10 more
  • (no location specified)
Feb 17, 2023

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Boston (Iadademstat, Gilteritinib Oral Tablet)

Recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • Boston, Massachusetts
  • +2 more
Jan 18, 2023

Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse Trial in Miami (Bomedemstat,

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Miami, Florida
    University of Miami
Dec 22, 2022

Tumor, Stomach, Gastric Tumors Malignant, Pancreatic Tumors Trial in Bogotá (Petiveria Alliacea Preparation, Placebo)

Not yet recruiting
  • Neoplasm, Stomach
  • +8 more
  • Petiveria Alliacea Preparation
  • Placebo
  • Bogotá, Colombia
    Pontificia Universidad Javeriana
Oct 16, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Seattle (SC-DARIC33)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • SC-DARIC33
  • Seattle, Washington
    Seattle Children's Hospital
Sep 6, 2022

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Edegem, Roeselare (Venetoclax, 6-mercaptopurine)

Recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • Edegem, Antwerp, Belgium
  • +1 more
Aug 16, 2022

Acute Myeloid Leukemia, in Relapse Trial in Baltimore, Chapel Hill (pembrolizumab,)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia, in Relapse
  • Baltimore, Maryland
  • +1 more
Aug 10, 2022

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti-siglec-6 CAR-T cell therapy)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Acute Myeloid Leukemia, in Relapse
  • anti-siglec-6 CAR-T cell therapy
  • Xuzhou, Jiangsu, China
    Kailin Xu
Aug 2, 2022

Immunobiology of Acute Myeloid Leukemia Relapses After

Recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Observations on Relapsed AML Allogeneic Transplanted patients
  • Milan, Milano, Italy
    IRCCS Ospedale San Raffaele
Jul 18, 2022

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, Myelodysplastic Syndrome Trial in Zhengzhou (6MW3211

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • +2 more
  • 6MW3211 injection with Intravenous Infusion
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Jul 2, 2022

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Myelodysplastic Syndrome Acute Myeloid Leukemia Trial in

Recruiting
  • Acute Myeloid Leukemia Refractory
  • +2 more
  • Houston, Texas
  • +4 more
Jun 23, 2022

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (Venetoclax, Azacitadine, Vorinostat)

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • (no location specified)
Apr 11, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse, NPM1 Mutation Trial in Bologna (Venetoclax+azacitidine)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Bologna, Italy
    EMATOLOGIA- AOU Policlinico S.Orsola
Mar 1, 2022

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (BP1002; Liposomal Bcl-2 Antisense

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • BP1002; Liposomal Bcl-2 Antisense Oligodeoxynucleotide
  • Decitabine (in combination with BP1002)
  • (no location specified)
Mar 8, 2022

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia, Pediatric, Acute Myeloid Leukemia, Refractory Trial in Philadelphia

Recruiting
  • Acute Myeloid Leukemia, in Relapse
  • +2 more
  • CART123 cells; cyclophosphamide; fludarabine
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Feb 28, 2022

Acute Myeloid Leukemia, in Relapse, Recurrent Adult Acute Myeloid Leukemia Trial in Boston (GO-203-2c, GO-203-2c + Decitabine)

Active, not recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Recurrent Adult Acute Myeloid Leukemia
  • Boston, Massachusetts
  • +1 more
Jan 25, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Aurora (KPT-9274)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Aurora, Colorado
  • +1 more
Aug 30, 2021

Recurrent Adult Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse Trial in Worldwide (MEN1112)

Terminated
  • Recurrent Adult Acute Myeloid Leukemia
  • Acute Myeloid Leukemia, in Relapse
  • Antwerp, Belgium
  • +28 more
Jul 5, 2021

Acute Myeloid Leukemia, in Relapse, MDS Trial in Australia, United States (CB-5339)

Recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Myelodysplastic Syndromes
  • Scottsdale, Arizona
  • +8 more
May 17, 2021

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia, Refractory Trial in New York, Hershey, Charlottesville (Ceramide

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia, Refractory
  • Ceramide NanoLiposome (Ceraxa)
  • New York, New York
  • +2 more
Jan 15, 2021